Cargando…

SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals

The aim of this study is to understand adaptive immunity to SARS-CoV-2 through the analysis of B cell epitope and neutralizing activity in coronavirus disease 2019 (COVID-19) patients. We obtained serum from forty-three COVID-19 patients from patients in the intensive care unit of Osaka University H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Shota, Ono, Chikako, Hayashi, Hiroki, Fukumoto, Shinya, Shiraishi, Satoshi, Tomono, Kazunori, Arase, Hisashi, Matsuura, Yoshiharu, Nakagami, Hironori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960719/ https://www.ncbi.nlm.nih.gov/pubmed/33723294 http://dx.doi.org/10.1038/s41598-021-85202-9

Ejemplares similares

Preclinical study of a DNA vaccine targeting SARS-CoV-2
por: Hayashi, Hiroki, et al.
Publicado: (2022)

AJP001, a novel helper T‐cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine
por: Tenma, Akiko, et al.
Publicado: (2019)

Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults
por: Nakagami, Hironori, et al.
Publicado: (2022)

Prevention of bleomycin-induced pulmonary fibrosis by a RANKL peptide in mice
por: Ju, Nan, et al.
Publicado: (2022)

Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant
por: Hayashi, Hiroki, et al.
Publicado: (2022)

Baculovirus as a Tool for Gene Delivery and Gene Therapy
por: Ono, Chikako, et al.
Publicado: (2018)

Establishment and clinical application of SARS-CoV-2 catch column
por: Isaka, Yoshitaka, et al.
Publicado: (2022)

Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis
por: Ju, Nan, et al.
Publicado: (2019)

Development of a novel antimicrobial peptide, AG-30, with angiogenic properties
por: Nishikawa, Tomoyuki, et al.
Publicado: (2009)

Therapeutic Effects of Systemic Administration of the Novel RANKL-Modified Peptide, MHP1, for Ischemic Stroke in Mice
por: Shimamura, Munehisa, et al.
Publicado: (2018)

Acquisition of Humoral Immune Responses in Convalescent Japanese People with SARS-CoV-2 (COVID-19) Infection in 2021
por: Monzen, Koshiro, et al.
Publicado: (2023)

Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice
por: Kawakami, Ryo, et al.
Publicado: (2018)

Production of hepatitis E virus-like particles presenting multiple foreign epitopes by co-infection of recombinant baculoviruses
por: Shima, Ryoichi, et al.
Publicado: (2016)

Humoral Epitope Spreading in Autoimmune Bullous Diseases
por: Didona, Dario, et al.
Publicado: (2018)

Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients
por: Lu, Xiuyuan, et al.
Publicado: (2021)

The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice
por: Yoshida, Shota, et al.
Publicado: (2020)

Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity
por: Yoshida, Akiho, et al.
Publicado: (2022)

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
por: Liu, Yafei, et al.
Publicado: (2021)

Novel Anti-Microbial Peptide SR-0379 Accelerates Wound Healing via the PI3 Kinase/Akt/mTOR Pathway
por: Tomioka, Hideki, et al.
Publicado: (2014)

A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice
por: Tokunoh, Nagisa, et al.
Publicado: (2023)

Therapeutic vaccine for chronic diseases after the COVID-19 Era
por: Nakagami, Hironori, et al.
Publicado: (2021)

Development of anti-thrombotic vaccine against human S100A9 in rhesus monkey
por: Shimamura, Munehisa, et al.
Publicado: (2021)

Tightly Regulated Expression of Autographa californica Multicapsid Nucleopolyhedrovirus Immediate Early Genes Emerges from Their Interactions and Possible Collective Behaviors
por: Ono, Chikako, et al.
Publicado: (2015)

Bioinformatics-based SARS-CoV-2 epitopes design and the impact of spike protein mutants on epitope humoral immunities
por: Sun, Qi, et al.
Publicado: (2022)

Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene
por: Takada, Kosuke, et al.
Publicado: (2023)

Humoral Alloimmunity in Transplantation: Relevance of HLA Epitope Antigenicity and Immunogenicity
por: Duquesnoy, René J.
Publicado: (2011)

The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies
por: Filippone, Edward J., et al.
Publicado: (2016)

Development of a novel RANKL-based peptide, microglial healing peptide1-AcN (MHP1-AcN), for treatment of ischemic stroke
por: Shimamura, Munehisa, et al.
Publicado: (2018)

Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19–convalescent individuals
por: Li, Min, et al.
Publicado: (2022)

Development of an IL-17A DNA Vaccine to Treat Systemic Lupus Erythematosus in Mice
por: Koriyama, Hiroshi, et al.
Publicado: (2020)

Modification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agents
por: Nakagami, Hironori, et al.
Publicado: (2012)

Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responses
por: Kawai, Atsushi, et al.
Publicado: (2023)

Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction
por: Torii, Shiho, et al.
Publicado: (2021)

GENERATING RESPONSES IMMUNE IN CELLULAR AND HUMORAL TREATMENT WITH EPITOPE SPIKE, EPITOPE ENVELOPE PROTEIN, AND EPITOPE MEMBRANE PROTEIN SARS-COV-2, HONEY, SAUSSUREA LAPPA, AND NIGELLA SATIVA
por: Prawiro, Sumarno Reto, et al.
Publicado: (2021)

Peptide-based vaccine targeting IL17A attenuates experimental spondyloarthritis in HLA-B27 transgenic rats
por: Hayashi, Hiroki, et al.
Publicado: (2023)

Neutralizing and enhancing antibodies against SARS-CoV-2
por: Liu, Yafei, et al.
Publicado: (2022)

Suppression of HBV replication by the expression of nickase- and nuclease dead-Cas9
por: Kurihara, Takeshi, et al.
Publicado: (2017)

Effect of prorenin peptide vaccine on the early phase of diabetic retinopathy in a murine model of type 2 diabetes
por: Yokota, Harumasa, et al.
Publicado: (2022)

Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction
por: Hayashi, Hiroki, et al.
Publicado: (2023)

Combining machine learning and nanopore construction creates an artificial intelligence nanopore for coronavirus detection
por: Taniguchi, Masateru, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_693ch077mu6tflrq43tinmegu6